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Objectives: To assess the consistency and reproducibility of quantitative susceptibility mapping (QSM) at 3T 
and 1.5T MR scanners. 
Materials and Methods: This study was approved by institutional ethics committee and written informed 
consent was obtained. Twenty-two healthy volunteers underwent two examinations on different days. Each 
examination consisted of MR imaging at both 3T and 1.5T MR scanners. The data from both scanners and 
examination days were obtained, and QSM was calculated with STI Suite using two different algorithms: 
HARmonic PhasE RemovaL using 
 LAplacian operator (HARPERELLA) and a SHARP method with a variable radius of the spherical kernel at 
the brain boundary (V-SHARP). We evaluated consistency of QSM between 3T and 1.5T, and the 
reproducibility between the 1st and 2nd examinations using two phase processing methods (HARPERELLA 
and V-SHARP). 
Results: Susceptibility values of regions of interests at 3T were highly correlated with those at 1.5T with good 
agreement (HARPERELLA: R2=0.838, V-SHARP: R2=0.898) (average difference ±1.96 standard deviation; 
HARPERELLA: -0.012±0.046, V-SHARP: -0.002±0.034). Reproducibility analysis demonstrated excellent 
correlation between the 1st and 2nd examination at both 3T and 1.5T for both algorithms (HARPERELLA at 
3T: R2=0.921, 1.5T: R2=0.891; V-SHARP at 3T: R2=0.937, 1.5T: R2=0.926). Bland-Altman analysis showed 
excellent reproducibility for HARPERELLA (at 3T: -0.003±0.032, 1.5T: -0.003±0.038) and V-SHARP (at 3T: 
-0.003±0.027, 1.5T: -0.003±0.029). Susceptibility values of these two algorithms were highly correlated with 
good agreement (3T: R2=0.961, 1.5T: R2=0.931) (3T: 0.009±0.023, 1.5T: -0.003±0.049). 
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Conclusion:  QSM with HARPERELLA and V-SHARP demonstrated good reproducibility at 3T and 1.5T, 
and QSM with V-SHARP demonstrated good consistency at 3T and 1.5T. 
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Quantitative Susceptibility Mapping (QSM) is a novel post-processing technique that uses gradient 
echo phase images to directly measure tissue magnetic susceptibility caused by various sources such as iron, 
myelin and physiological calcification 1-4. Phase images have provided good tissue contrast and allowed the 
detection of intrinsic iron content changes 5, 6, however, phase images are influenced by background phase 
originating objects outside of a region of interest as well as phase wrapping 7, 8. In comparison, QSM provides 
a more intrinsic measure of tissue magnetic susceptibility and has become a promising tool 4, 9-15. 
Susceptibility values calculated from QSM have been reported to have a strong correlation with iron 
concentration in human brain especially in deep gray matter structures 14, 16-18. Abnormal concentration of iron 
stores in human brain was demonstrated in various neurological diseases, for example in the basal ganglia and 
active demyelinating lesion for multiple sclerosis 19, in hippocampus and cerebral cortex for Alzheimer’s 
disease 20, 21, and in substantia nigra for Parkinson’s disease 22. It has been shown that QSM provides excellent 
depiction of brain lesions in a number of neurologic diseases and disorders, including microbleeds 23, multiple 
sclerosis 24, 25, brain tumors 26, intracranial calcifications and hemorrhages 27, and neurodegenerative diseases 
28-30. 
QSM of human brain has already been applied to research and clinical applications at various field 
strength including 7T, 3T and 1.5T. Currently, near all clinical MR scans are performed at 3T and 1.5T. 
However, to our knowledge, no reports have focused on the comparison of susceptibility values at 3T and 
1.5T, nor the reproducibility on each static magnetic field. Because QSM is a quantitative measurement, we 
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hypothesized that QSM values measured at 3T and 1.5T should be equivalent in the same subjects. Therefore, 
the purpose of this study was to assess the consistency of magnetic susceptibility of human brains between 3T 
and 1.5T MR scanners, using STI Suite provided by Duke University which has been considerably applied to 
research and clinical imaging 8. We also investigated the reproducibility of susceptibility values at each MR 
scanner and the association between two different algorithms for background phase removal in calculating 
QSM. We acknowledge that there are a growing number of QSM algorithms available and it is not realistic to 
evaluate all existing methods in a single study. However, as different algorithms improve, their results are 
expected to converge thus the main findings of this study will hold as the algorithms become more mature. 
Accordingly, the purpose of this study was to assess the consistency and reproducibility of QSM at 3T and 
1.5T MR scanners. 
 
Materials and Methods 
Phantom preparation 
A gadolinium (Gd) phantom was constructed for in-vitro validation study to measure susceptibility 
values in comparison with theoretical values. 2% agarose gels in spherical form (diameter 2.5cm) with various 
concentration of gadoterate meglumine (Gd-DOTA) (Dotarem, Guerbet, Villepinte, France) were fixed in a 
cubic container filled with water. Gd agarose gels contained Gd concentration of 0.25%, 0.5%, 0.75%, 1.0%, 
1.25%, and 1.5%, corresponding to theoretical susceptibility values of 0.41 ppm, 0.81 ppm, 1.22 ppm, 1.63 




Human subjects  
This prospective study was approved by the institutional ethics committee and a written informed 
consent was obtained for each participant, and 22 healthy volunteers were enrolled (17 men, 5 women; age 
range, 23–41 years; mean age, 30.2 years ± 5.2 [standard deviation]). All subjects underwent 2 examinations 
on different days. Each examination consists of MR imaging at both 3T and 1.5T MR scanners on a single day 
without delays: Specifically, MR imaging was conducted at 3T first, then, subsequently at 1.5T immediately 
after the 3T scan on the 1st examination day. On the 2nd examination day, MR imaging was conducted at 1.5T 
first, then at 3T. The interval between the 1st and 2nd examination was maintained at around 20 days. None 
of the volunteers had a history of neurologic, psychiatric, ophthalmologic or cardiovascular diseases. 
MR imaging 
MR imaging was performed on a 3T scanner (Vantage, Toshiba Medical Systems, Otawara, Japan) 
using a 32-channel head coil and on a 1.5T scanner (Excelart Vantage Powered by Atlas, Toshiba Medical 
Systems, Otawara, Japan) using a 12-channel head coil. 
Three-dimensional (3D) gradient-echo images for QSM calculation were acquired for the Gd 
phantom and human subjects at both 3T and 1.5T using a 3D single-echo T2*-weighted field echo sequence 
with the following parameters: repetition time (TR), 60 msec; echo time (TE), 40 msec; flip angle, 20°; 
resolution, 1 × 1 × 1 mm; a parallel imaging factor of 3 in phase-encoding direction. The acquisition time was 
14 minutes and 26 seconds. For anatomical reference of human subjects, 3D T1-weighted IR prepared fast 
field echo images (TR, 5.9 msec; TE, 2.7 msec; inversion time, 900 msec; flip angle, 9°; resolution, 1.2 × 1 × 
1.2 mm; parallel imaging factor of 2 in phase-encoding direction and 1.5 in slice direction; acquisition time, 
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5 minutes 47 seconds) were also acquired at 3T. These T1-weighted images were used for brain segmentation 
and Diffeomorphic Anatomical Registration using Exponentiated Lie Algebra (DARTEL) template 32. 
Image processing for Gd phantom 
QSM calculation was conducted from the phase of 3D gradient echo images in STI Suite version 2.10 
(http://people.duke.edu/~cl160/). Mask images were generated from magnitude images by threshold for 
background phase removal. For phase unwrapping and back ground phase removal, we conducted two 
different algorithms: (i) integrated phase unwrapping and background phase removal by HARmonic PhasE 
RemovaL using LAplacian operator (HARPERELLA) method, and (ii) a SHARP method with a variable 
radius of the spherical kernel at the brain boundary (V-SHARP) 8, 14. QSM with HARPERELLA and QSM 
with V-SHARP were then calculated from each local tissue phase by solving an inverse problem using the 
iLSQR method (an algorithm for sparse linear equations and sparse least squares) 8, 33. The strength of the 
static magnetic field was calculated from the central frequency and gyromagnetic ratio of water of each MR 
scan. 
QSM with HARPERELLA and QSM with V-SHARP at the 3T and 1.5T were compared with the 
theoretical susceptibility values respectively. QSM values were compared between 3T and 1.5T to evaluate 
consistency of susceptibility values. 
Image Processing for human subjects 
The process of calculating and creating QSM images in Montreal Neurological Institute (MNI) space 
(http://www.mni.mcgill.ca/) for human subjects is outlined in Fig. 1. QSM calculation was conducted from 
the phase of 3D gradient echo images in STI Suite version 2.10. Skull stripped brain masks were generated 
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from magnitude images with Brain Extraction tool (BET), FSL (http://www.fmrib.ox.ac.uk/fsl/) for 
background phase removal 34. We conducted the HARPERELLA method and the V-SHARP method 8, 14. QSM 
with HARPERELLA and QSM with V-SHARP were then calculated from each local tissue phase by the 
iLSQR method8. The strength of the static magnetic field was calculated from the central frequency and 
gyromagnetic ratio of water of each MR scan. 
3D T1-weighted images were co-registered to the corresponding magnitude images by using SPM8 
software (Wellcome Department of Imaging Neuroscience, University College London, UK) implemented in 
MATLAB 2013b (Mathworks, Natick, Massachusetts, US). A DARTEL template was generated from the 
entire image dataset using DARTEL import files. In the next step, all co-registered 3D T1-weighted images 
were mapped to the MNI space using nonlinear warping 32. QSM images were transformed into MNI space 
with a Gaussian filter (full width at half maximum [1, 1, 1 mm]) by using DARTEL imported files and 
normalized QSM images with 1-mm isotropic voxel were created (Fig. 2). 
Regions of interest for human subjects 
 A single set of regions of interest (ROIs) was manually created by a neuroradiologist (6 years of 
experience [rater A]) in consultation with another neuroradiologist (17 years of experience [rater B]) on the 
averaged normalized QSM images of all the subjects: caudate head, putamen, globus pallidus, internal capsule, 
red nucleus, substantia nigra, and dentate nucleus, using the ImageJ software (National Institutes of Health, 
Bethesda, MD, USA) (Fig. 3). This set of ROIs was applied to the individual QSM maps derived from 
HARPERELLA and V-SHARP method for the 1st and 2nd examinations at 3T and 1.5T. Susceptibility values 
were calculated as the magnetic susceptibility in parts per million (ppm) for all voxels identified in each ROI 
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projected onto each individual QSM maps. In addition to the single set of ROIs on normalized QSM images, 
ROIs on individual original QSM images were created to check the validity of the susceptibility values 
between original QSM images and normalized QSM images. In particular, to assess the intra- and 
interobserver variability, rater A and rater B respectively created ROIs on individual original QSM images, 
and rater A created the other ROIs in two-week interval. 
Consistency analysis of QSM between 3T and 1.5T 
The total 44 QSM maps derived with HARPERELLA from both the 1st and 2nd examinations at 3T 
were compared with those at 1.5T by using the single set of ROIs on normalized QSM images defined above. 
QSM maps derived with V-SHARP were compared between 3T and 1.5T in the same way. 
Reproducibility analysis of QSM between 1st and 2nd examinations 
 In this analysis, the total 22 QSM maps at 3T of the 1st examinations and those of the 2nd 
examinations were compared with respect to each QSM phase processing methods (HARPERELLA and V-
SHARP) by using ROIs described above. In the same way, QSM maps at 1.5T were also compared.  
Comparison analysis of QSM between HARPERELLA and V-SHARP methods 
 The total 44 QSM maps derived with HARPERELLA from both the 1st and 2nd examinations at 3T 
were compared with the corresponding QSM maps derived with V-SHARP at 3T. The same ROIs described 
above were used. Similarly at 1.5T, QSM maps derived with HARPERELLA were compared with the 
corresponding QSM maps derived with V-SHARP. 
Statistical analysis 
All statistical analyses were conducted by using MedCalc version 13.3 (MedCalc Software bvba, 
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Ostend, Belgium). Susceptibility values of phantom experiments were assessed using regression analysis 
(slope, R2). Susceptibility values of the single set of ROIs were assessed using regression analysis (slope, R2) 
and Bland-Altman analysis of 95% limits of agreement (average difference ± 1.96 standard deviation of the 
difference). Intra- and interobserver variability using interclass correlation coefficients (ICC) was evaluated 
by the single set of ROIs on normalized QSM and the manual ROIs on the individual original QSM of rater A 
(first time [#1]), (second time [#2]) and rater B, and Bland-Altman plots of 95% limits of agreement (average 
difference ± 1.96 standard deviation of the difference) were conducted between the single set of ROIs and the 




 QSM images of the Gd phantom at each MR scanner were shown in Fig. 4. Susceptibility values of 
each spherical Gd agarose gel were correlated with the theoretical susceptibility values derived from Gd 
concentration (see Figure, Supplemental Digital Content 1): HARPERELLA at 3T: slope = 0.990, R2 = 0.977; 
3T, V-SHARP at 3T: slope = 0.960, R2 = 0.995; HARPERELLA at 1.5T: slope =1.059, R2 = 0.981; V-SHARP 
at 1.5T: slope = 1.006, R2 = 0.991. In addition, excellent consistency was demonstrated between 3T and 1.5T: 
HARPERELLA: slope = 0.934, R2 = 0.995; V-SHARP: slope = 1.048, R2 = 0.997. 
Region of interest for human subjects 
Susceptibility values of the single set of ROIs derived from HARPERELLA and V-SHARP of the 22 




Mean susceptibility values by the single set of ROIs and each rater were shown in Figure, 
Supplemental Digital Content 2. Intraobserver agreement rates were as follows: HARPERELLA at 3T: 0.961 
(95% confidence interval [CI]: 0.954, 0.966), V-SHARP at 3T: 0.966 (95% CI: 0.961, 0.971), HARPERELLA 
at 1.5T: 0.974 (95% CI: 0.970, 0.978), V-SHARP at 1.5T: 0.970 (95% CI: 0.965, 0.974). Interobserver 
agreement rates were as follows: HARPERELLA at 3T: 0.948 (95% CI: 0.941, 0.954), V-SHARP at 3T: 0.950 
(95% CI: 0.944, 0.956), HARPERELLA at 1.5T: 0.944 (95% CI: 0.937, 0.951), V-SHARP at 1.5T: 0.949 (95% 
CI: 0.942, 0.955). Bland-Altman analysis also showed excellent agreement between the raters on original 
QSM and the single set of ROIs on normalized QSM: HARPERELLA at 3T: -0.003 ppm ± 0.037, V-SHARP 
at 3T: -0.001 ppm ± 0.036, HARPERELLA at 1.5T: 0.003 ppm ± 0.041, V-SHARP at 1.5T: 0.004 ppm ± 0.032. 
Consistency analysis of QSM between 3T and 1.5T 
Susceptibility values with HARPERELLA at 3T were highly correlated with those at 1.5T (slope = 
0.899, R2 = 0.838) (Fig. 5a). Susceptibility values with V-SHARP at 3T were also highly correlated with those 
at 1.5T (slope = 0.964, R2 = 0.898) (Fig. 5b). QSM with V-SHARP was better correlated between the two field 
strengths than was QSM with HARPERELLA. Bland-Altman analysis showed good agreement in QSM with 
HARPERELLA (-0.012 ppm ± 0.046) (Fig. 5c) and better agreement with V-SHARP (-0.002 ppm ± 0.034) 
(Fig. 5d). 
Reproducibility analysis of QSM between 1st and 2nd examinations 
Susceptibility values of the 1st study and the 2nd study were also highly correlated at both magnets 
(QSM with HARPERELLA at 3T: slope = 0.950, R2 =0.921 (Fig. 6a); at 1.5T: slope = 0.965, R2 = 0.891 (Fig. 
10 
 
6b)) (QSM with V-SHARP at 3T: slope = 0.971, R2 = 0.937 (Fig. 6c); at 1.5T: slope = 0.969, R2 = 0.926 (Fig. 
6d)). Bland-Altman analysis showed excellent agreement for both methods at both fields: HARPERELLA at 
3T (-0.003 ppm ± 0.032) (Fig. 6e) and 1.5T (-0.003 ppm ± 0.038) (Fig. 6f); V-SHARP at 3T (-0.003 ppm ± 
0.027) (Fig. 6g) and 1.5T (-0.003 ppm ± 0.029) (Fig. 6h). 
Comparison analysis of QSM between HARPERELLA and V-SHARP methods 
 Susceptibility values derived from these two different background phase removal algorithms were 
compared with each other. QSM with HARPERELLA were also highly correlated with QSM with V-SHARP 
(3T: slope = 0.924, R2 = 0.961 (Fig. 7a); 1.5T: slope = 0.878, R2 = 0. 931 (Fig. 7b)). Bland-Altman analysis 
also showed good agreement between the two algorithms at 3T (0.009 ppm ± 0.023) (Fig. 7c) and 1.5T (-
0.003 ppm ± 0.049) (Fig. 7d). 
 
Discussion 
The result of Gd phantom experiments and consistency analysis of QSM between 3T and 1.5T in 
human subjects showed good correlation with little variance of susceptibility values for both HARPERELLA 
and V-SHARP methods. Magnetic susceptibility of a given object is theoretically an invariable value 
independent of static magnetic fields, therefore susceptibility values at 3T and 1.5T should be theoretically 
identical. This study has confirmed our initial hypothesis that susceptibility values measured at 3T and 1.5T 
should be equivalent in the same subject to be true. Phase unwrapping was well conducted and consistent 
QSM results were achieved with the single-echo sequence which might cause phase unwrapping error and 
phase variation due to the B1 variation. Background fields resulting from paranasal sinus and mastoid air cells 
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are much severer at 3T than 1.5T, however, our results demonstrated that susceptibility values derived with 
HARPERELLA and V-SHARP at both magnets were in good agreement in spite of unfavorable circumstances 
of background field at 3T. Our results support that QSM is a reliable quantification method to measure 
magnetic susceptibility longitudinally at different magnets, and probably more consistently with the V-SHARP 
method compared to HARPERELLA.  
Reproducibility of susceptibility values in human subjects over two time points was excellent both at 
3T and at 1.5T and for both the HARPERELLA and the V-SHARP method. This excellent reproducibility 
indicates that both algorithms are reliable for serial evaluation of susceptibility values with limited variance. 
High reproducibility of susceptibility values is important for longitudinal tissue evaluation and for comparison 
study between normal controls and patients. Although reproducibility of QSM at 3T scanners was assessed 36, 
there have been no prior reports demonstrating the consistency and reproducibility of QSM at different static 
magnetic fields, therefore, our data provide the critical evidences suggesting good reproducibility of QSM for 
clinical usage. 
Comparison analysis of QSM between HARPERELLA and V-SHARP methods revealed good 
correlation between the two different algorithms. Since reproducible results were demonstrated in both 
algorithms throughout this study, both algorithms were consistent with each other with high reproducibility. 
Previous report demonstrated that HARPERELLA is a robust technique for phase unwrapping and back 
ground phase removal and preserves the low spatial frequency components of the brain tissue which is 
important for QSM 8. HARPERELLA preserves the Laplacian of the phase image outside the brain by using 
L2 norm minimization, on the contrary, V-SHARP method was conducted after the Laplacian-based phase 
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unwrapping where the phase Laplacian outside the brain was assumed to be zero 8. In addition, V-SHARP 
method was conducted with smaller radius of the spherical kernel at the brain boundary compared with those 
in the center of the brain 14. Some phase differences around the brain structure and blood vessels located on 
the surface were observed due to the differences of the two algorithms, which may be the reason of the slightly 
decreased correlation between HARPERELLA and V-SHARP. 
 QSM has been developed as a valuable tool for imaging and quantifying tissue magnetic properties. 
Although previous Gd phantom experiments were mainly performed using multi-echo sequences, our Gd 
phantom experiments using the single-echo sequence shows excellent correlation with the theoretical 
susceptibility values. Previous Cadaver studies have demonstrated a strong correlation between QSM and iron 
concentration of deep gray matter calculated from age 16, 18. In this study, although the estimated iron content 
in deep gray matters were in good correspondence to QSM values of each ROIs in the deep gray matter (data 
not shown), the relationship between QSM and iron derived from cadavers might be different from that in 
living human being. The reproducibility of QSM in live subjects cannot be evaluated with phantoms or 
cadavers because magnetic susceptibility varies with physical conditions 37. 
 Susceptibility reference is an unresolved issue for QSM. In some studies, cerebrospinal fluid (CSF) 
was used as the reference 12, 17, however, susceptibility values of CSF are heterogeneous 18. The ventricles are 
not homogenous structures with blood vessels, choroid plexus, small size and complicated shapes susceptible 
to partial volume effects; in addition, CSF flow and its composition of lipids and proteins can affect its 
magnetic susceptibility values. Other studies set the susceptibility in white matter to 0 ppm or -0.03 ppm as 
reference 13, 18. Susceptibility values of white matter, however, is also non-uniform and easily vary, because of 
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myelination and anisotropy of white matter affects QSM values. In this study, we did not calibrate 
susceptibility values with CSF space or white matter, but our study demonstrates good consistency. Further 
studies are needed to optimize the calibration methods of QSM.  
There are some limitations in this study. First, all ROIs were manually created on averaged QSM 
maps of all the subjects. Theoretically, the single set of ROIs works for all the subjects because all the QSM 
maps were normalized in MNI space, and susceptibility values of manual ROIs on individual QSM showed 
excellent correspondence to the single set of ROIs regardless of MNI transformation. Second, we evaluated 
only the posterior limb of internal capsule and no other white matter structures were evaluated. It is well 
known that fiber orientation heavily affect magnetic susceptibility of white matter 9. Because of this anisotropy, 
white matter in general is not appropriate for ROI based analysis. The posterior limb of internal capsule is a 
suitable ROI due to its relatively consistent orientation with respect to the magnetic field. Third, subjects of 
this study are relatively young and the number of subjects is relatively small. Further studies of various age 
group and larger number of subjects are required. Fourth, Signal to noise ratio (SNR) at 3T is better than that 
at 1.5T, which has not been taken into consideration in this study, however, susceptibility values at 1.5T were 
almost equal to those at 3T in spite of lower SNR at 1.5T. Fifth, some orientation differences among subjects 
and examinations may exist, which might have affected the results of QSM 12. Reproducible head positioning 
may lead to better consistency and reproducibility of QSM. Finally, we compared only two phase processing 
methods and only with STI Suite. However, it is reasonable to project that, as the algorithms improve, other 
state-of-the-art QSM techniques should provide similarly consistent and reproducible results. The goal of our 
study was not meant to provide an exhaustive comparisons of the ever growing number of QSM algorithms. 
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Rather, it serves to illustrate that the principles behind QSM are able to produce consistency and 
reproducibility values between different time points and between different magnets. 
In conclusion, QSM with HARPERELLA and V-SHARP demonstrated good reproducibility at 3T 
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Figure Legends  
 
Figure 1  
Flowchart for calculating and normalizing QSM with HARPERELLA and V-SHARP. (1) Phase 
unwrapping and back ground phase removal was conducted for the phase images of 3D gradient echo images 
with HARPRELLA or V-SHARP method. (2) Skull stripped magnitude images of 3D gradient echo images 
by using BET tool were applied to the process of (1) as brain masks. (3) QSM was calculated from tissue 
phase images by using iLSQR to solve ill posed inverse problem. (4) DARTEL template was calculated by 
3D T1-weighted images. (5) QSM was transformed into MNI space using the DARTEL template. 
 
Figure 2 
 Average and normalized QSM images of all subjects at the level of the cerebellum, brain stem, and 
basal ganglia: (a) QSM at 3T with HARPERELLA and (b) with V-SHARP, and (c) QSM at 1.5T with 
HARPERELLA and (d) with V-SHARP. 
 
Figure 3 
A common set of regions of interests was created on the averaged and normalized QSM images: 
caudate nucleus, putamen, globus pallidus, and posterior limb of internal capsule at the level of the basal 





 QSM images of Gd Phantom (agarose gels contained Gd concentration of 0.25%, 0.5%, 0.75%, 1.0%, 
1.25%, and 1.5%, corresponding to susceptibility values of 0.41 ppm, 0.81 ppm, 1.22 ppm, 1.63 ppm, 2.04 
ppm, and 2.45 ppm). (a) QSM at 3T with HARPERELLA, (b) with V-SHARP, (c) QSM at 1.5T with 
HARPERELLA, (d) with V-SHARP and (e) T2-weighted image. 
 
Figure 5 
  Scattered plots and Bland-Altman plots of the consistency analysis of susceptibility values between 
3T and 1.5T. Scattered plots show linear regression analysis of (a) susceptibility values with HARPERELLA 
between 3T and 1.5T and (b) susceptibility values with V-SHARP. Solid lines in the top panel indicate linear 
regression lines (slope). Bland-Altman plots show mean susceptibility difference between 3T and 1.5T and 
limits of agreement (± 1.96 standard deviation, dash lines) for the assessment of (c) susceptibility values with 
HARPERELLA between 3T and 1.5T, and (d) with V-SHARP between 3T and 1.5T. 
 
Figure 6 
  Scattered plots and Bland-Altman plots of reproducibility analysis of susceptibility values between 
1st and 2nd examinations. Scattered plots show linear regression analysis of (a) susceptibility values with 
HARPERELLA between the 1st and 2nd examination at 3T, (b) with HARPERELLA at 1.5T, (c) with V-
SAHRP at 3T, and, (d) with V-SHARP at 1.5T. Solid lines indicate linear regression (slope). Bland-Altman 
plots show mean susceptibility difference between the 1st and 2nd examination and limits of agreement (± 
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1.96 standard deviation, dash lines) for the assessment of (e) susceptibility values with HARPERELLA at 3T, 
(f) with HARPERELLA at 1.5T, (g) with V-SHARP at 3T, and, (h) with V-SHARP at 1.5T. 
 
Figure 7 
Scattered plots and Bland-Altman plots of comparison analysis of susceptibility values between 
HARPERELLA and V-SHARP. Scattered plots show linear regression analysis of (a) susceptibility values 
between HARPERELLA and V-SHARP methods at 3T and (b) at 1.5T. Solid lines indicate linear regression 
(slope). Bland-Altman plots show mean susceptibility difference between HARPERELLA and V-SHARP and 
limits of agreement (± 1.96 standard deviation, dash lines) for the assessment of (c) susceptibility values 






Susceptibility values and standard deviation per region of interest. Mean ± SD. [ppm] 
 




Caudate Nucleus  0.042 ± 0.017  0.038 ± 0.011  0.037 ± 0.019  0.038 ± 0.012 
Dentate Nucleus  0.084 ± 0.025  0.071 ± 0.022  0.094 ± 0.024  0.070 ± 0.020 
Globus Pallidus  0.141 ± 0.024  0.123 ± 0.020  0.129 ± 0.024  0.130 ± 0.021 
Putamen  0.063 ± 0.015  0.052 ± 0.011  0.050 ± 0.017  0.053 ± 0.012 
Red Nucleus  0.071 ± 0.029  0.068 ± 0.026  0.048 ± 0.025  0.056 ± 0.022 
Substantia nigra  0.100 ± 0.024  0.093 ± 0.018  0.073 ± 0.028  0.083 ± 0.021 





Supplemental Digital Content 1 
 Scattered plots of the region of interest analysis. Scattered plots show linear regression analysis with 
theoretical susceptibility values of (a) measured susceptibility values at 3T with HARPERELLA, (b) with V-
SHARP, (c) at 1.5T with HARPERELLA, and (d) with V-SHARP. Linear regression analysis between 3T and 
1.5T (e) with HARPERELLA and (f) V-SHARP. 
 
Supplemental Digital Content 2 
Mean susceptibility values by the single set of ROIs and each rater on (a) QSM with HARPERELLA 
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Supplemental Digital Content 1 
 Scattered plots of the region of interest analysis. Scattered plots show linear regression analysis 
with theoretical susceptibility values of (a) measured susceptibility values at 3T with HARPERELLA, (b) 
with V-SHARP, (c) at 1.5T with HARPERELLA, and (d) with V-SHARP. Linear regression analysis 
between 3T and 1.5T (e) with HARPERELLA and (f) V-SHARP. 
 
Supplemental Digital Content 2 
Mean susceptibility values by the single set of ROIs and each rater on (a) QSM with 
HARPERELLA at 3T, (b) with V-SHARP at 3T, (c) with HARPERELLA at 1.5T and (d) with V-SHARP at 
1.5T.  
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